Chemomab Therapeutics Statistics
Total Valuation
CMMB has a market cap or net worth of $20.68 million. The enterprise value is $9.89 million.
| Market Cap | 20.68M |
| Enterprise Value | 9.89M |
Important Dates
The next estimated earnings date is Thursday, November 7, 2024, before market open.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CMMB has 14.36 million shares outstanding. The number of shares has increased by 19.04% in one year.
| Shares Outstanding | 14.36M |
| Shares Change (YoY) | +19.04% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 12.70% |
| Owned by Institutions (%) | 8.83% |
| Float | 8.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.23 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.12, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.12 |
| Quick Ratio | 3.11 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -93.80% and return on invested capital (ROIC) is -61.70%.
| Return on Equity (ROE) | -93.80% |
| Return on Assets (ROA) | -46.18% |
| Return on Capital (ROIC) | -61.70% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$749,850 |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -55,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +70.48% in the last 52 weeks. The beta is 0.29, so CMMB's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | +70.48% |
| 50-Day Moving Average | 1.60 |
| 200-Day Moving Average | 1.03 |
| Relative Strength Index (RSI) | 46.93 |
| Average Volume (20 Days) | 153,552 |
Short Selling Information
| Short Interest | 72,487 |
| Short Previous Month | 58,584 |
| Short % of Shares Out | 0.39% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.25 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.03M |
| Pretax Income | -19.36M |
| Net Income | -15.00M |
| EBITDA | -15.97M |
| EBIT | -16.03M |
| Earnings Per Share (EPS) | -$1.12 |
Balance Sheet
The company has $12.73 million in cash and $360,000 in debt, giving a net cash position of $12.37 million or $0.86 per share.
| Cash & Cash Equivalents | 12.73M |
| Total Debt | 360,000 |
| Net Cash | 12.37M |
| Net Cash Per Share | $0.86 |
| Equity (Book Value) | 9.99M |
| Book Value Per Share | 0.70 |
| Working Capital | 9.15M |
Cash Flow
| Operating Cash Flow | -16.13M |
| Capital Expenditures | n/a |
| Free Cash Flow | -16.13M |
| FCF Per Share | -$1.12 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CMMB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.04% |
| Shareholder Yield | -19.04% |
| Earnings Yield | -67.38% |
| FCF Yield | -72.47% |
Analyst Forecast
The average price target for CMMB is $5.67, which is 293.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.67 |
| Price Target Difference | 293.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -53.28% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |